GSK 366 is a highly potent and selective inhibitor of kynurenine-3-monooxygenase (KMO), exhibiting IC50 values of 0.7 nM and 2.3 nM against the bacterial and human enzymes, respectively. This small molecule is a valuable research tool for investigating the kynurenine pathway in models of neurodegenerative and inflammatory diseases, both in vitro and in vivo.
Molekulargewicht:
361.78
CAS Nummer:
[1953157-39-5]
Formel:
C17H16ClN3O4
Target-Kategorie:
Hydroxylase,Others
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten